{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:44:27Z","timestamp":1793641467798,"version":"4.5.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14840-3","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:54:10Z","timestamp":1759229650000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Sustained PSA screening is associated with downstaging and improved survival in prostate cancer: a 12-year Korean cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Jung Kwon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Uk","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwa Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teakjun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myungsun","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Suk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalsan","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Gab","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryn","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Hyuk","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choung-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanjong","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"3","key":"14840_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"14840_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.4143\/crt.2022.179","volume":"54","author":"KW Jung","year":"2022","unstructured":"Jung KW, Won YJ, Kang MJ, Kong HJ, Im JS, Seo HG. Prediction of cancer incidence and mortality in korea, 2022. Cancer Res Treat. 2022;54(2):345\u201351.","journal-title":"Cancer Res Treat"},{"issue":"8","key":"14840_CR3","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1001\/jamaoncol.2015.6310","volume":"2","author":"R Etzioni","year":"2016","unstructured":"Etzioni R, Gulati R. Recent trends in PSA testing and prostate cancer incidence: a look at context. JAMA Oncol. 2016;2(8):955\u20136.","journal-title":"JAMA Oncol"},{"issue":"2","key":"14840_CR4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","volume":"157","author":"VA Moyer","year":"2012","unstructured":"Moyer VA. Screening for prostate cancer: U.S. Preventive services task force recommendation statement. Ann Intern Med. 2012;157(2):120\u201334.","journal-title":"Ann Intern Med"},{"issue":"13","key":"14840_CR5","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1002\/cncr.31549","volume":"124","author":"S Negoita","year":"2018","unstructured":"Negoita S, Feuer EJ, Mariotto A, Cronin KA, Petkov VI, Hussey SK, et al. Annual report to the Nation on the status of cancer, part II: recent changes in prostate cancer trends and disease characteristics. Cancer. 2018;124(13):2801\u201314.","journal-title":"Cancer"},{"issue":"12","key":"14840_CR6","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1001\/jamaoncol.2022.4319","volume":"8","author":"AK Bryant","year":"2022","unstructured":"Bryant AK, Lee KM, Alba PR, Murphy JD, Martinez ME, Natarajan L, et al. Association of prostate-specific antigen screening rates with subsequent metastasis incidence at US veterans health administration facilities. JAMA Oncol. 2022;8(12):1747\u201355.","journal-title":"JAMA Oncol"},{"issue":"1","key":"14840_CR7","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"9959","key":"14840_CR8","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1016\/S0140-6736(14)60525-0","volume":"384","author":"FH Schr\u00f6der","year":"2014","unstructured":"Schr\u00f6der FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V, et al. Screening and prostate cancer mortality: results of the European randomized study of screening for prostate cancer at 13 years of follow-up. Lancet. 2014;384(9959):2027\u201335.","journal-title":"Lancet"},{"issue":"4","key":"14840_CR9","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/cncr.30474","volume":"123","author":"PF Pinsky","year":"2017","unstructured":"Pinsky PF, Prorok PC, Yu K, Kramer BS, Black A, Gohagan JK, et al. Extended mortality results for prostate cancer screening in the PLCO trial with 15-year follow-up. Cancer. 2017;123(4):592\u20139.","journal-title":"Cancer"},{"key":"14840_CR10","doi-asserted-by":"publisher","first-page":"e077738","DOI":"10.1136\/bmj-2023-077738","volume":"380","author":"S Vaccarella","year":"2024","unstructured":"Vaccarella S, Li M, Bray F, Kvale R, Serraino D, Lorenzoni V, et al. Prostate cancer incidence and mortality in Europe and implications for screening: a population-based study. BMJ. 2024;380:e077738.","journal-title":"BMJ"},{"issue":"5","key":"14840_CR11","first-page":"549","volume":"21","author":"JL Mohler","year":"2023","unstructured":"Mohler JL, Antonarakis ES, Armstrong AJ, D\u2019Amico AV, Davis BJ, Dorff T, et al. Prostate cancer, version 2.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2023;21(5):549\u201369.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"14840_CR12","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1186\/s12885-019-6164-5","volume":"19","author":"AV Sarma","year":"2019","unstructured":"Sarma AV, Skolarus TA, Roberts J, Cooney KA, Montie JE, Wei JT. Screening for prostate cancer: A review of the ERSPC and PLCO trials. BMC Cancer. 2019;19(1):947.","journal-title":"BMC Cancer"},{"issue":"9","key":"14840_CR13","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1097\/01.pas.0000173646.99337.b1","volume":"29","author":"JI Epstein","year":"2005","unstructured":"Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL. The 2005 ISUP consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol. 2005;29(9):1228\u201342.","journal-title":"Am J Surg Pathol."},{"issue":"2","key":"14840_CR14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","volume":"40","author":"JI Epstein","year":"2016","unstructured":"Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA, et al. The 2014 ISUP consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol. 2016;40(2):244\u201352.","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"14840_CR15","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1002\/cncr.20586","volume":"101","author":"PJ Bastian","year":"2004","unstructured":"Bastian PJ, Mangold LA, Epstein JI, Partin AW. Characteristics of insignificant clinical T1c prostate tumors: a contemporary analysis. Cancer. 2004;101(9):2001\u20135.","journal-title":"Cancer"},{"issue":"1","key":"14840_CR16","doi-asserted-by":"publisher","first-page":"428","DOI":"10.18632\/oncotarget.20787","volume":"9","author":"L Xu","year":"2018","unstructured":"Xu L, Wang J, Guo B, Zhang H, Wang K, Wang D, et al. Comparison of clinical and survival characteristics between PSA-detected and clinically diagnosed prostate cancer in China. Oncotarget. 2018;9(1):428\u201341.","journal-title":"Oncotarget"},{"issue":"6","key":"14840_CR17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/iju.13563","volume":"25","author":"T Hashimoto","year":"2018","unstructured":"Hashimoto T, Ohori M, Shimodaira K, Kaburaki N, Hirasawa Y, Satake N, et al. Prostate-specific antigen screening impact on outcomes of patients with clinically localized prostate cancer. Int J Urol. 2018;25(6):561\u20137.","journal-title":"Int J Urol"},{"key":"14840_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2407-5-27","volume":"5","author":"RM Hoffman","year":"2005","unstructured":"Hoffman RM, Stone SN, Espey D, et al. Differences between men with screening-detected versus clinically diagnosed prostate cancers in the USA. BMC Cancer. 2005;5:27.","journal-title":"BMC Cancer"},{"issue":"22","key":"14840_CR19","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1200\/JCO.2015.61.6532","volume":"33","author":"MW Drazer","year":"2015","unstructured":"Drazer MW, Huo D, Eggener SE. National prostate cancer screening rates after the 2012 USPSTF recommendation. J Clin Oncol. 2015;33(22):2416\u201323.","journal-title":"J Clin Oncol"},{"issue":"12","key":"14840_CR20","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1001\/jamaoncol.2016.2667","volume":"2","author":"A Jemal","year":"2016","unstructured":"Jemal A, Ma J, Siegel R, et al. Prostate cancer incidence rates two years after the US preventive services task force recommendations against screening. JAMA Oncol. 2016;2(12):1657\u201360.","journal-title":"JAMA Oncol"},{"issue":"9","key":"14840_CR21","doi-asserted-by":"publisher","first-page":"e33521","DOI":"10.1016\/j.urolonc.2016.03.014","volume":"34","author":"AC Reese","year":"2016","unstructured":"Reese AC, Wessel SR, Fisher SG, Mydlo JH. Evidence of prostate cancer reverse stage migration toward more advanced disease at diagnosis. Urol Oncol. 2016;34(9):e33521\u20138.","journal-title":"Urol Oncol"},{"issue":"8","key":"14840_CR22","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1111\/j.1464-410X.2010.09982.x","volume":"108","author":"L Budaus","year":"2011","unstructured":"Budaus L, Spethmann J, Isbarn H, Schmitges J, Beesch L, Haese A, et al. Inverse stage migration in patients undergoing radical prostatectomy: results of 8,916 European patients treated within the last decade. BJU Int. 2011;108(8):1256\u201361.","journal-title":"BJU Int"},{"issue":"4","key":"14840_CR23","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.eururo.2014.02.051","volume":"66","author":"AB Weiner","year":"2014","unstructured":"Weiner AB, Etzioni R, Eggener SE. Ongoing Gleason grade migration in localized prostate cancer and implications for use of active surveillance. Eur Urol. 2014;66(4):611\u20132.","journal-title":"Eur Urol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14840-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14840-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14840-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:30:30Z","timestamp":1759275030000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14840-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14840"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14840-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Asan Medical Center (IRB No. 2016\u2009\u2212\u20091099). Informed consent was waived by the IRB due to the retrospective design of the study involving anonymized clinical data. This study was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1462"}}